[Activities of folate-derivative converting enzymes in the brain of patients with amyotrophic lateral sclerosis].
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology*; D000818:Animals; D001921:Brain / Q000201:enzymology*; D005260:Female; D012696:Glycine Hydroxymethyltransferase / Q000378:metabolism*; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008780:Methyltransferases / Q000378:metabolism*; D008875:Middle Aged; D009474:Neurons / Q000201:enzymology; D051381:Rats; D014166:Transferases / Q000378:metabolism*
D000429:Alcohol Oxidoreductases; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D042965:Methylenetetrahydrofolate Reductase (NADPH2); D014166:Transferases; D008780:Methyltransferases; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D012696:Glycine Hydroxymethyltransferase